期刊文献+

血尿琥珀酰丙酮检测在酪氨酸血症-I型诊断中的应用 被引量:12

Application of suceinylacetone levels measurement in the blood and urine in the diagnosis of tyrosinemia type 1
原文传递
导出
摘要 目的 探讨血、尿琥珀酰丙酮检测在酪氨酸血症-Ⅰ型诊断中的价值.方法 对临床疑似酪氨酸血症、血串联质谱检测酪氨酸水平增高的190例患儿,进行血串联质谱琥珀酰丙酮检测、尿气相色谱-质谱琥珀酰丙酮及有机酸检测.确诊条件为临床表现、血酪氨酸增高及血或尿琥珀酰丙酮增高.结果 确诊酪氨酸血症-Ⅰ型患儿11例,男9例,女2例,年龄2个月至6岁.患儿血琥珀酰丙酮显著升高( 14.2±7.8) μmol/L(参考值1~5μmol/L).其中7例患儿进行了尿气相色谱-质谱琥珀酰丙酮检测,4例阳性,3例阴性.血酪氨酸水平为(327.3±125.8) μmol/L(参考值为20 ~ 100μmol/L).临床表现均有肝肿大.结论 血或尿琥珀酰丙酮升高是诊断酪氨酸血症-Ⅰ型的最重要依据.串联质谱检测血琥珀酰丙酮较气相色谱-质谱检测尿琥珀酰丙酮对诊断酪氨酸血症-Ⅰ型更可靠,气相色谱-质谱尿琥珀酰丙酮检测可能导致假阴性. Objective To establish the diagnostic method of tyrosinemia type 1 and evaluate its value,the succinylacetone levels in the blood of suspected patients with tyrosinemia were tested by tandem mass spectrometry, and the succinylacetone in the urine was tested by gas chromatography-mass spectrometry.Method A total of 190 patients suspected of having tyrosinemia,were tested by tandem mass spectrometry for measurement of the level of succinylacetone in the blood, and detected by gas chromatography-mass spectrometry for measurement of the level of succinylacetone and organic acid in the urine.The method of measuring the level of succinylacetone in blood by tandem mass spectrometry as follows: After the diameter of 3 mm dry blood spots were punched into wells of 96-well plate,100 μl 80%acetonitrile were added into each well,which contained hydrazine monohydrate and the internal standard of succinylacetone.The supernatant fluid were transferred to another 96-well plate and dried under heated nitrogen,after the plate was incubated for 30 min at 65 ℃.The residual hydrazine reagent was removed by addition of 100 μl methanol to each well and evaporated under heated nitrogen.The mobile phase ( 80%acetonitrile) was added to each well and 20 μ1 samples were tested by tandem mass spectrometry.The diagnostic terms were the clinical manifestation and the high level of succinylacetone in both blood and urine.Result Eleven patients were diagnosed as tyrosinemia type 1,with 9 males and 2 females.Their ages ranged from 2 months to 6 years.The succinylacetone levels in the blood of the patients were remarkably increased (7.26- 31.09 μmol/L),with an average of (14.2 ± 7.8 )μmol/L.Seven patients were tested for the level of succinylacetone in the urine by gas chromatography-mass spectrometry,and 4 were positive and 3 negative.Their tyrosine levels in the blood were 190 -543 μmol/L (Normal:20 - 100 μmol/L),with an average of (327.3 ± 125.8) μmol/L.All the patients presented the symptoms of hepatomegaly.Among them,9 patients died and 2 patients were improved after treatment.Conclusion The higher levels of succinylacetone in the blood or urine is a remarkable evidence for the diagnosis of tyrosinemia type 1.Determination of succinylacetone in the dry blood spots using tandem mass spectrometry was a good method for diagnosis of tyrosinemia type 1.To test succinylacetone in urine by gas chromatography-mass spectrometry may yield a false-negative result for tyrosinemia type 1.
出处 《中华儿科杂志》 CAS CSCD 北大核心 2012年第2期126-130,共5页 Chinese Journal of Pediatrics
基金 基金项目:十一五国家科技支撑计划课题(2006AB105A05,2006BA105A07) 国家高技术发展计划(2007AA022447) 上海市卫生局重大课题(2008ZD001) 上海市卫生局科研课题(2009210)
关键词 酪氨酸血症 串联质谱法 气相色谱.质谱法 Tyrosinemias Tandem mass spectrometry Gas chromatography-mass spectrometry
  • 相关文献

参考文献18

  • 1Chakrapani A, Holme E. Disorders of tyrosine metabolism// Fernandes J, Saudubray JM, Berghe G, et al. Inborn Metabolic Diseases. 4th ed. Germany: Springer, 2006: 233-243.
  • 2Rashed MS, Ahaidib LY, A1-Dirbashi OY, et al. Tandem mass spectrometric assay of succinylacetone in urine for the diagnosis of hepatorenal tyrosinemia. Analytical Biochemistry, 2005, 339 : 310-317.
  • 3顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:144
  • 4Allard P, Grenier A, Korson MS, et al. Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots. Clin Biochem, 2004,37 : 1010-1015.
  • 5韩连书,叶军,邱文娟,高晓岚,王瑜,金晶,顾学范.串联质谱联合气相色谱-质谱检测遗传性代谢病[J].中华医学杂志,2008,88(30):2122-2126. 被引量:60
  • 6Masurel-Paulet A, Poggi-Bach J, Rolland MO, et al. NTBC treatment in tyrosinaemia type I: long-term outcome in French.patients. J Inherit Metab Dis,2008, 31:81-87.
  • 7Ohura T, Kobayashi K, Tazawa Y, et al. Clinical pictures of 75 patients with neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD). J Inherit Metal) Dis, 2007, 30:139-144.
  • 8Matern D, Tortorelli S, Oglesbee D, et al. Reduction of the false- positive rate in newborn screening by implementation of MS/MS- based second-tier tests: the Mayo Clinic experience (2004-2007). J Inherit Metab Dis,2007,30: 585-592.
  • 9A1-Dirbashi OY, Fisher L, McRoberts C, et al. Identification of a neonate with hepatorenal tyrosinemia by combined routine newborn screening for succinylacetone, acylcarnitines and amino acids. Clin Bioehem, 2010, 43:691-693.
  • 10Turgeon C, Magera MJ, A11ard P, et al. Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots. Clin Chem,2008 ,54 :657-664.

二级参考文献39

  • 1顾学范,韩连书,高晓岚,杨艳玲,叶军,邱文娟.串联质谱技术在遗传性代谢病高危儿童筛查中的初步应用[J].中华儿科杂志,2004,42(6):401-404. 被引量:144
  • 2韩连书,高晓岚,叶军,邱文娟,顾学范.串联质谱技术在有机酸血症筛查中的应用研究[J].中华儿科杂志,2005,43(5):325-330. 被引量:64
  • 3李晓瑜,杜敏联,庄思齐,莫恩明,马华梅,李燕虹,陈红珊,丘小汕.遗传性酪氨酸血症Ⅰ型10例的临床诊断分析[J].中华儿科杂志,2006,44(6):470-471. 被引量:13
  • 4Zytkovicz TH, Fitzgerald EF, Marsden D, et al. Tandem mass spectrometry analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem, 2001, 47: 1945 -1955.
  • 5Chace DH, Kales TA. A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing. Clin Biochem, 2005, 38 : 296-309.
  • 6Garg U, Dasouki M. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: clinical and laboratory aspect. Clin Biochem, 2006, 39 : 315 -332.
  • 7Frazier DM, Millington DS, McCandless SE, et al. The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis, 2006, 29: 76-85.
  • 8Schulze A, Lindner M, KohlmuUer D, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics, 2003,111: 1399-1406.
  • 9Yoon HR, Lee Kit, Kang S, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Claim Acta, 2005, 354:167-180.
  • 10Huang HP, Chu KL, Chien YH, et al. Tandem mass neonatal screening in taiwan- report firm one center. J Formos Med Assoc, 2006, 105 : 882-886.

共引文献205

同被引文献106

引证文献12

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部